Rhythm Pharma Outlines Robust Start To Newly Approved Drug For Genetic Condition
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) announced that over 35 physicians have written 50+ prescriptions for Imcivree (setmelanotide) for Bardet-Biedl syndrome…
Vaxxinity’s Vaccine Candidate Shows Durable Cholesterol Lowering Activity In Animal Models
Vaxxinity Inc (NASDAQ:VAXX) announced data demonstrating durable lowering of low-density lipoprotein (LDL) cholesterol in non-human primates. The company also selected VXX-401…
Syneos Health Stock Tanks After Q2 Sales Miss, FY22 Outlook Cut Citing Macro Economic Trends
Syneos Health Inc’s (NASDAQ:SYNH) Q2 revenue increased 6.1% on a reported basis and 8.3% on a constant currency (CC)…
IDEXX Laboratories Misses on Q2 Earnings, Issues FY22 Guidance Below Consensus
IDEXX Laboratories Inc (NASDAQ:IDXX) reported Q2 revenues of $861 million, an increase of 4% Y/Y on a reported basis and…
Conformis Shares Jump On Personalized Orthopedic Implants Contract
Conformis Inc (NASDAQ:CFMS) entered into a multi-year agreement with Vizient Inc to offer personalized orthopedic implants to Vizient’s membership of healthcare facilities. The…
Zimmer Biomet Raises FY22 Outlook As Q2 Performance Exceeds Expectations
Zimmer Biomet Holdings Inc’s (NYSE:ZBH) Q2 sales increased by 1% Y/Y to $1.78 billion (up 6% on a constant currency basis),…
DuPont Revises Annual Guidance, Trails Wall Street Estimates, Shares Tick Lower
DuPont de Nemours Inc (NYSE: DD) Q2 sales increased 7% Y/Y to $3.3 billion, missing the consensus of $4.2 billion.
SEC Charges 11 People In $300M Crypto Ponzi Scheme
The Securities and Exchange Commission has charged 11 people for their roles in creating and promoting an allegedly fraudulent crypto-focused…
AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement
Sosei Group Corporation and AbbVie Inc (NYSE:ABBV) announced a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules…
Acadia Healthcare Earns 12% Price Target Bump ‘On Strong Q2’
RBC Capital Markets raised the price target on Acadia Healthcare Company Inc (NASDAQ:ACHC) to $94 from $84 with an Outperform rating unchanged.…